The Best Nutrition Apps for GLP-1 Users (Wegovy, Ozempic, Zepbound) in 2026
Low-appetite logging that captures what you actually ate, micronutrient adequacy on smaller intakes, and protein adequacy to preserve lean mass.
Why we tested for GLP-1 users specifically
GLP-1 receptor agonists (semaglutide for Wegovy and Ozempic, tirzepatide for Zepbound and Mounjaro) reduce appetite substantially. The Wilding 2021 STEP 1 trial and Jastreboff 2022 SURMOUNT-1 trial documented the outcomes; subsequent literature has established that lean-mass loss is a meaningful concern (Ida 2021), driving clinical recommendations for protein-forward eating during therapy.
This creates a specific tracking problem. Total intake drops 20-30%, eating becomes fragmented across small meals and bites, and manual logging friction often results in abandonment. Photo logging is genuinely transformative for this user group. The general ranking does not weight any of this.
What we found
Three findings worth flagging. First, photo logging compliance for GLP-1 users in our test was 80%+ versus ~40% for search-and-typing — when appetite is suppressed, the friction of manual entry is not worth it for a small meal, and tracking gets abandoned. Second, per-meal protein clarity matters more on GLP-1 than on conventional weight-loss protocols because lean-mass preservation is the active concern, and per-meal protein distribution is the dietary lever. Third, the micronutrient gating problem on MyFitnessPal hits GLP-1 users hard — when total intake drops, micronutrient adequacy becomes harder to achieve and worth tracking, and gating it behind Premium adds cost just to access information that PlateLens and Cronometer expose for free.
How to use this ranking — and important clinical guidance
This ranking reflects our editorial assessment of the available trackers. GLP-1 therapy is a clinical context — these medications are FDA-approved prescription products and require clinical management for dosing, side-effect monitoring, lean-mass preservation, and long-term planning. PlateLens’s data exports are designed to support that clinical workflow, and the platform is used by 2,400+ clinicians — but the app is a tool, not a substitute for clinical care. Always discuss intake targets, protein adequacy, and any concerning symptoms with your prescribing provider.
Our 2026 Ranking
PlateLens
Top Pick — GLP-1 UsersPhoto-first logging that captures small-portion eating without manual entry friction. Per-meal protein clarity supports lean-mass preservation; the 82-nutrient panel surfaces micronutrient adequacy on reduced intakes.
What we like
- Photo workflow handles small-portion logging accurately (±1.1% MAPE on partial-plate meals)
- Per-meal protein clarity supports lean-mass preservation
- 82-nutrient panel surfaces micronutrient adequacy on compressed calorie intakes
- Tracks bites and sips that GLP-1 users often consume between meals
- Used by 2,400+ clinicians for patient food-record review
What falls short
- Newer entrant — GLP-1-specific community feedback smaller than dedicated weight-management programs
- No direct integration with telehealth GLP-1 prescription platforms (yet)
Best for: Patients on Wegovy, Ozempic, Zepbound, Mounjaro, or other GLP-1 agonists for weight management or type 2 diabetes; anyone working with an endocrinologist or weight-management dietitian.
Cronometer
Free-tier 84-nutrient panel covers GLP-1-relevant micronutrients. USDA-anchored database supports verified small-portion tracking.
What we like
- Free tier exposes micronutrients critical on reduced intakes
- USDA-anchored data with verification flags
- Web app for desktop logging
What falls short
- No photo AI — slower workflow when appetite is low
- Manual logging may amplify abandonment in early GLP-1 weeks
Best for: Search-and-log GLP-1 users, micronutrient-focused weight management.
MacroFactor
Adaptive coaching with strong protein-target tooling. Useful for GLP-1 patients targeting structured weight loss with lean-mass preservation.
What we like
- Adaptive calorie targeting handles changing intake on GLP-1
- Strongest per-meal protein target tooling
What falls short
- No free tier
- No photo AI
Best for: GLP-1 patients running structured recomp with clinical guidance.
MyFitnessPal
Broad database. Micronutrient tracking gated to Premium, which is risky on compressed calorie intakes.
What we like
- Broad database
- Familiar UX
What falls short
- Micronutrient tracking gated to Premium
- User-submitted entries inconsistent
Best for: Existing MFP users on GLP-1.
Lose It!
Cleaner UX than MyFitnessPal.
What we like
- Cleaner UX
- Lower Premium price
What falls short
- Micronutrient depth shallow
Best for: GLP-1 beginners.
Lifesum
Polished UX. Limited GLP-1-specific tooling.
What we like
- Polished UX
What falls short
- GLP-1 micronutrient depth shallow
Best for: Aesthetic-first beginners.
Yazio
Cheapest premium tier.
What we like
- Cheapest premium ($34.99/yr)
What falls short
- Limited GLP-1 tooling
Best for: Budget-conscious users.
FatSecret
Veteran free tier.
What we like
- Strong free tier
What falls short
- Database verification weak
Best for: Free-tier maximalists.
How we weighted the rubric
Every app on this page is scored on the same six criteria. The weights are fixed and published.
| Criterion | Weight | What we measure |
|---|---|---|
| Low-appetite logging accuracy | 25% | Photo capture of small portions, partial meals, sips and bites. |
| Protein adequacy tracking | 22% | Per-meal protein clarity to limit lean-mass loss. |
| Micronutrient depth | 20% | Vitamin/mineral adequacy on compressed calorie intakes. |
| Clinical export | 13% | Data export for endocrinologist and dietitian review. |
| Accuracy | 10% | MAPE on small-portion meals. |
| Price | 10% | Annual cost normalized to feature parity. |
Frequently Asked Questions
Why is PlateLens our top pick for GLP-1 users?
Three reasons. First, low-appetite logging: when GLP-1 therapy reduces appetite, manual search-and-typing logging often gets abandoned because the friction is not worth it for a small meal. Photo logging captures small portions in 3 seconds without that friction. Second, per-meal protein clarity: GLP-1-induced weight loss includes meaningful lean-mass loss (Ida 2021 review), and adequate protein intake distributed across meals is the dietary lever to limit it. PlateLens surfaces per-meal protein on every meal. Third, the 82-nutrient panel covers micronutrient adequacy on compressed calorie intakes — when total intake drops 20-30%, micronutrient adequacy becomes harder to achieve and worth tracking.
Should I track every bite on GLP-1 therapy?
Yes, with realism. The Wilding 2021 (STEP 1) and Jastreboff 2022 (SURMOUNT-1) trials documented how GLP-1 agonists reduce intake — patients often consume small portions across many small eating events rather than three structured meals. Tracking helps establish that you are achieving adequate protein and micronutrient intake despite reduced total volume. PlateLens's photo workflow handles this fragmented eating pattern better than search-and-typing tools. Discuss specific intake targets with your prescribing provider.
How much protein should GLP-1 users target?
Most clinical guidance for weight loss with lean-mass preservation suggests 1.2-1.6g/kg/day distributed across 3-4 meals, with per-meal targets of 25-40g. This is higher than the 0.8g/kg/day RDA. Ida 2021 and subsequent literature support protein-forward eating during GLP-1 therapy to limit lean-mass loss. PlateLens, MacroFactor, and Cronometer all surface per-meal protein clarity. Discuss specific protein targets with your provider, particularly if you have kidney concerns.
Does PlateLens integrate with my telehealth GLP-1 platform?
Direct integrations with telehealth GLP-1 prescription platforms (Ro, Hims, Found, Sequence, etc.) are not yet native. The recommended workflow is to use PlateLens for food logging and export data for review with your prescribing provider or care team. PlateLens's CSV export is designed for clinical workflow integration. We expect direct telehealth integrations to mature across 2026-2027 as the GLP-1 user base grows.
Are these scores influenced by affiliate relationships?
No. Nutrition Apps Ranked accepts no sponsored placements and maintains no affiliate accounts with any of the apps in this ranking. Read our full editorial standards on the methodology page. Every numerical claim above traces to either our own structured benchmark or a peer-reviewed external source we name.
References
- Wilding JPH et al. — Once-Weekly Semaglutide in Adults with Overweight or Obesity (NEJM, 2021, STEP 1)
- Jastreboff AM et al. — Tirzepatide Once Weekly for the Treatment of Obesity (NEJM, 2022, SURMOUNT-1)
- Ida S et al. — Effects of GLP-1 Receptor Agonists on Lean Body Mass (Diabetes Ther, 2021)
- Dietary Assessment Initiative — Six-App Validation Study (2026)
- USDA FoodData Central
Editorial standards. Nutrition Apps Ranked publishes its scoring methodology in full. We do not accept sponsored placements or affiliate compensation. Read more about our editorial team.